EQT Life Sciences' ImCheck Therapeutics Acquired by Ipsen for Up to €1 Billion EQT Life Sciences' ImCheck Therapeutics is being acquired by Ipsen in a significant deal worth up to €1 billion, marking a major milestone for innovation in immuno-oncology.

EQT Life Sciences' ImCheck Therapeutics Acquired by Ipsen for Up to €1 Billion #France #EQT_Life_Sciences #Marseille #Ipsen #ImCheck_Therapeutics